发明名称 |
MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS |
摘要 |
The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. |
申请公布号 |
US2016324803(A1) |
申请公布日期 |
2016.11.10 |
申请号 |
US201615215456 |
申请日期 |
2016.07.20 |
申请人 |
Forest Laboratories Holdings Limited |
发明人 |
Rastogi Suneel K.;Rao Niranjan;Periclou Antonia;Abramowitz Wattanaporn;Dedhiya Mahendra G.;Mahashabde Shashank |
分类号 |
A61K31/13;A61K9/20;A61K9/00 |
主分类号 |
A61K31/13 |
代理机构 |
|
代理人 |
|
主权项 |
1. A modified release solid oral dosage form comprising:
(a) at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and (b) a pharmaceutically acceptable polymeric carrier substantially contributing to the modification of the release of said active ingredient,said dosage form sustaining release of said therapeutically active agent from about 4 hours to about 24 hours following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. |
地址 |
Hamilton BM |